LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 104 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $261,186 | -58.5% | 239,620 | -12.7% | 0.00% | – |
| Q2 2023 | $628,704 | +30.5% | 274,543 | +38.4% | 0.00% | – |
| Q1 2023 | $481,879 | +85.7% | 198,304 | +46.0% | 0.00% | – |
| Q4 2022 | $259,457 | -35.9% | 135,842 | -19.7% | 0.00% | – |
| Q3 2022 | $405,000 | -61.7% | 169,083 | -70.3% | 0.00% | – |
| Q2 2022 | $1,057,000 | +171.0% | 568,908 | +204.9% | 0.00% | – |
| Q1 2022 | $390,000 | -8.7% | 186,582 | +72.0% | 0.00% | – |
| Q4 2021 | $427,000 | -10.9% | 108,468 | +8.9% | 0.00% | – |
| Q3 2021 | $479,000 | -22.6% | 99,575 | -26.1% | 0.00% | – |
| Q2 2021 | $619,000 | -85.0% | 134,761 | -80.9% | 0.00% | -100.0% |
| Q1 2021 | $4,140,000 | -41.8% | 705,138 | -66.1% | 0.00% | 0.0% |
| Q4 2020 | $7,114,000 | +255.7% | 2,080,137 | +49.8% | 0.00% | – |
| Q3 2020 | $2,000,000 | -50.3% | 1,388,442 | -31.1% | 0.00% | -100.0% |
| Q2 2020 | $4,022,000 | +1189.1% | 2,016,181 | +1160.9% | 0.00% | – |
| Q1 2020 | $312,000 | -83.0% | 159,902 | -63.8% | 0.00% | – |
| Q4 2019 | $1,835,000 | +28.4% | 442,246 | -6.9% | 0.00% | – |
| Q3 2019 | $1,429,000 | +16.3% | 474,852 | +143.1% | 0.00% | – |
| Q2 2019 | $1,229,000 | +191.9% | 195,307 | +158.0% | 0.00% | – |
| Q1 2019 | $421,000 | -55.0% | 75,696 | -46.2% | 0.00% | – |
| Q4 2018 | $935,000 | -1.6% | 140,787 | +58.2% | 0.00% | – |
| Q3 2018 | $950,000 | -46.2% | 88,965 | -39.6% | 0.00% | – |
| Q2 2018 | $1,767,000 | +93.8% | 147,205 | +38.2% | 0.00% | – |
| Q1 2018 | $912,000 | -17.6% | 106,505 | -4.9% | 0.00% | – |
| Q4 2017 | $1,107,000 | -13.7% | 111,999 | +7.3% | 0.00% | – |
| Q3 2017 | $1,283,000 | +8.6% | 104,371 | +45.3% | 0.00% | – |
| Q2 2017 | $1,181,000 | -76.4% | 71,814 | -79.5% | 0.00% | -100.0% |
| Q1 2017 | $5,010,000 | +27.1% | 349,530 | +22.7% | 0.00% | 0.0% |
| Q4 2016 | $3,942,000 | +80.6% | 284,978 | +135.9% | 0.00% | 0.0% |
| Q3 2016 | $2,183,000 | +565.5% | 120,780 | +428.0% | 0.00% | – |
| Q2 2016 | $328,000 | -42.8% | 22,876 | -52.2% | 0.00% | – |
| Q1 2016 | $573,000 | +1119.1% | 47,901 | +1282.4% | 0.00% | – |
| Q4 2015 | $47,000 | -74.2% | 3,465 | -79.6% | 0.00% | – |
| Q3 2015 | $182,000 | -39.7% | 16,957 | -54.8% | 0.00% | – |
| Q2 2015 | $302,000 | – | 37,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
| SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
| NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
| Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
| Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
| MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
| USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
| CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
| WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |